• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tourmaline Bio, Inc. - Common Stock (NQ:TRML)

47.98 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tourmaline Bio, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA), Veeco Instruments Inc. (Nasdaq - VECO), Tourmaline Bio, Inc. (Nasdaq -
October 17, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRML, CCRD, PBBK on Behalf of Shareholders
October 09, 2025
From Halper Sadeh LLC
Via GlobeNewswire
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened ↗
September 09, 2025
Via Stocktwits
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates FSFG, ARIS, TRML on Behalf of Shareholders
October 07, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA), Veeco Instruments Inc. (Nasdaq - VECO), Tourmaline Bio, Inc. (Nasdaq -
October 07, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
October 06, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WOW, PRO, TRML, PGRE on Behalf of Shareholders
September 22, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: PROS Holdings, Inc. (NYSE – PROS), Paramount Group, Inc. (NYSE – PGRE), Tourmaline Bio, Inc. (Nasdaq - TRML), WideOpenWest, Inc. (NYSE - WOW)
September 22, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, WOW, TRML, BTBD on Behalf of Shareholders
September 17, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paramount Group, Inc. (NYSE – PGRE), Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW)
September 17, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
This New Mountain Finance Analyst Turns Bearish; Here Are Top 3 Downgrades For Monday ↗
September 15, 2025
 
Via Benzinga
News headline image
Unusual volume stocks in Thursday's session ↗
September 11, 2025
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
TOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
September 11, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark ↗
September 10, 2025
U.S. markets closed higher on Tuesday, buoyed by fresh labor data signaling a cooling job market—potentially paving the way for Fed rate cuts. Nebius soared nearly 50% on a multibillion-dollar AI-cloud... 
Via Chartmill
Topics Economy
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
September 09, 2025
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Dow Surges Over 100 Points; Korn Ferry Earnings Top Views ↗
September 09, 2025
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 09, 2025
 
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRML, WOW, BTBD, WKHS on Behalf of Shareholders
September 09, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW), Workhorse Group Inc. (Nasdaq - WKHS)
September 09, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tourmaline Bio, QMMM Holdings, Teck Resources And Other Big Stocks Moving Higher On Tuesday ↗
September 09, 2025
 
Via Benzinga
News headline image
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense' ↗
September 09, 2025
Novartis agreed to buy a cardiovascular-focused biotech company 
Via Investor's Business Daily
News headline image
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion ↗
September 09, 2025
Tourmaline Bio shares skyrocketed Tuesday after Novartis agreed to buy the cardiovascular-focused biotech company. 
Via Investor's Business Daily
News headline image
Novartis To Expand Heart Drug Portfolio With $1.4 Billion Tourmaline Bio Acquisition ↗
September 09, 2025
Novartis agreed to acquire Tourmaline Bio for $1.4 billion as pacibekitug shows strong trial results for inflammation and cardiovascular risk reduction. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
September 09, 2025
 
Via Benzinga
News headline image
Why Nebius Group Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket ↗
September 09, 2025
 
Via Benzinga
News headline image
TRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to Shareholders
September 09, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Shareholder Alert: The Ademi Firm investigates whether Tourmaline Bio, Inc. is obtaining a Fair Price for its Public Shareholders
September 09, 2025
From The Ademi Firm
Via Business Wire
News headline image
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
September 09, 2025
From Tourmaline Bio, Inc.
Via GlobeNewswire
News headline image
Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress
August 31, 2025
From Tourmaline Bio, Inc.
Via GlobeNewswire
News headline image
Tourmaline Bio Reports Loss as R&D Rises ↗
August 13, 2025
Via The Motley Fool
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap